Radiotherapy

Institutional peer review led to recommended changes in more than one-quarter of radiotherapy treatment plans, according to results of a systematic review and meta-analysis.

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious long-term urinary and bowel complications, according to results of a meta-analysis published in Lancet Oncology.

Patients with nasopharyngeal carcinoma who received radiotherapy in the morning survived longer than those who underwent radiotherapy later in the day, according to study results.

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related cardiac events than those treated with other EGFR tyrosine kinase inhibitors.

Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally advanced squamous cell carcinoma of the head and neck.

More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past 2 decades despite shifts toward active surveillance, according to results of a retrospective study.

Common treatments for breast cancer — including chemotherapy, radiation and surgery — may accelerate biological aging among breast cancer survivors, according to results of a longitudinal, observational study.

SAN ANTONIO — Tamoxifen lowered overall and invasive ipsilateral recurrence among women with “good-risk” ductal carcinoma in situ who opted for breast conservation surgery without radiation.

The addition of veliparib to adjuvant temozolomide failed to improve OS for patients with newly diagnosed, MGMT-hypermethylated glioblastoma, according to randomized phase 2/phase3 study results.